Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease

NCT06066476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1022

Last updated 2025-02-20

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy and safety of the GENOSS DES in patients with coronary artery disease in real-world pratice.

Conditions

Sponsors & Collaborators

  • Genoss Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-24
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06066476 on ClinicalTrials.gov